Recap: Catalyst Pharmaceuticals Q4 Earnings

Catalyst Pharmaceuticals CPRX reported its Q4 earnings results on Wednesday, March 16, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Catalyst Pharmaceuticals missed estimated earnings by 25.0%, reporting an EPS of $0.09 versus an estimate of $0.12.

Revenue was up $7.29 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 4.54% increase in the share price the next day.

Here's a look at Catalyst Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.